Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer

Carol Waldo Also Joins Leadership Team as Head of Regulatory Affairs CAMBRIDGE, Mass., May 22, 2017 -- (Healthcare Sales & Marketing Network) -- Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment o... Biopharmaceuticals, Personnel Spero Therapeutics, multidrug resistant
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news